Document is current
Any future updates will be listed below
-
Authors
Sharma, Satya Pal
Moe-Nilssen, Rolf
Kvåle, Alice
Bærheim, Anders
-
Funding
Funding for this research was provided by:
General Practice Research Fund of The Norwegian Medical Association.
Dr. Trygve Gythfeldt and wife’s research fund (None)
- License Information
-
More Information
Article History
Received: 4 April 2017
Accepted: 25 August 2017
First Online: 2 September 2017
Ethics approval and consent to participate
: The study is performed in accordance with the Declaration of Helsinki and is approved by the Regional Ethical Committee (REK nord), UiT Norges Arktiske Universitet, Postboks Langnes, 9037 Tromsø, Norway; rek-nord@asp.uit.no. Project EUDRACT-NR 2008-004385-49; reference 200804384-7/KST017/400 and reference for change in protocol (2012) 2012/717/REK nord. The Norwegian Social Science Data Services (reference: 19675/2/SM) has accepted handling of data regarding personal information of patients and given its consent for the project. The Norwegian Medicine Agency has given its consent regarding use of Triamcinolone acetonide in this study, reference 08/18009 (post@legemiddelverket.no). The study is registered withExternalRef removed(ExternalRef removed/) identifier: NCT01570985 where the protocol is also available. Signed informed consent was obtained from all patients on inclusion in the study.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
